Detalhe da pesquisa
1.
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge.
Immunity
; 54(8): 1869-1882.e6, 2021 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34270939
2.
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.
Nature
; 586(7830): 567-571, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32756549
3.
Characterization of humoral and cellular immunologic responses to an mRNA-based human cytomegalovirus vaccine from a phase 1 trial of healthy adults.
J Virol
; 98(4): e0160323, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38526054
4.
CD4 T cells in protection from influenza virus: Viral antigen specificity and functional potential.
Immunol Rev
; 284(1): 91-105, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29944766
5.
T cell immunity to SARS-CoV-2 following natural infection and vaccination.
Biochem Biophys Res Commun
; 538: 211-217, 2021 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190827
6.
A Novel Vaccine Strategy to Overcome Poor Immunogenicity of Avian Influenza Vaccines through Mobilization of Memory CD4 T Cells Established by Seasonal Influenza.
J Immunol
; 203(6): 1502-1508, 2019 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399519
7.
CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection.
J Virol
; 92(13)2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29669836
8.
OMIP-061: 20-Color Flow Cytometry Panel for High-Dimensional Characterization of Murine Antigen-Presenting Cells.
Cytometry A
; 95(12): 1226-1230, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31424632
9.
Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection.
J Virol
; 90(17): 7991-8004, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27356897
10.
Seasonal Influenza Can Poise Hosts for CD4 T-Cell Immunity to H7N9 Avian Influenza.
J Infect Dis
; 212(1): 86-94, 2015 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25492919
11.
Altering the mRNA-1273 dosing interval impacts the kinetics, quality, and magnitude of immune responses in mice.
Front Immunol
; 13: 948335, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36426367
12.
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine.
Front Immunol
; 12: 772864, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34956199
13.
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
Science
; 373(6556)2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210892
14.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants.
bioRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655252
15.
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.
Cell Rep
; 33(4): 108322, 2020 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33091382
16.
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness.
bioRxiv
; 2020 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577634
17.
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.
SSRN
; : 3639618, 2020 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32742241
18.
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes.
bioRxiv
; 2020 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32596696
19.
A proof of concept for structure-based vaccine design targeting RSV in humans.
Science
; 365(6452): 505-509, 2019 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371616
20.
Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection.
Methods Mol Biol
; 1836: 513-530, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151589